Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
The peptide influences vasomotor tone through the Src-caveolin-1-eNOS pathway, affecting both vasoconstriction and vasodilation depending on baseline vascular state
For hip injuries including bursitis, tendinopathy, and soft tissue damage, typical protocols involve 0.25 to 0.5 mg daily via subcutaneous injection near the affected area for 4 to 8 weeks
Two collagen types dominate: Type I collagen (mature tendon structure) Type III collagen (early repair phase) In rodent studies, BPC-157-treated tendons showed: Increased type I collagen deposition Improved fiber parallel alignment Better biomechanical strength This suggests influence over: TGF- signalling Matrix metalloproteinases (MMPs) Extracellular matrix remodelling enzymes Balanced ECM remodelling prevents disorganized scar tissue
"Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin, L-NAME and L-arginine." PLoS ONE, 2020
